Stabilized filtration device
By coating polymeric membrane structures with a silica layer, the stability and functionality of integral membrane proteins are enhanced, addressing the durability issues in biomimetic water filtration technologies and enabling effective filtration devices.
Patent Information
- Application Number
- JP2024135593
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-02-27
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing biomimetic water filtration technologies face challenges in achieving stability and practical implementation due to the limited durability of integral membrane proteins, such as aquaporins, which are essential for high selectivity and flux in water treatment processes.
Coating the surface of polymeric membrane structures containing integral membrane proteins with a silica layer to enhance stability while maintaining their functionality, thereby forming a stable and functional filtration device.
The silica coating stabilizes the membrane structures, allowing them to be used effectively in filtration devices, enhancing their mechanical properties and operational life, and maintaining high water permeability.
Smart Images

Figure 2024161025000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates generally to polymeric membrane structures and filtration devices including such polymeric membrane structures and their use, for example, in water filtration. [Background technology]
[0002] Access to clean water has been defined by the United Nations as a human right, yet hundreds of millions of people lack access to clean drinking water and are at immediate risk of being exposed to toxic levels of contaminants in their drinking water.
[0003] Water treatment includes drinking water purification and wastewater treatment, both of which typically involve several stages of treatment to reach a desired level of purity. Filtration is commonly used in these processes, for example to prevent undesirable compounds in drinking water and to limit the amount of pollution caused to marine ecosystems by wastewater discharges.
[0004] Filters used in water treatment can be divided into two main categories: size-exclusion filters and solution-diffusion filters. Size-exclusion filters have a specific pore size and therefore prevent substances larger than the pores from entering the filtrate, also called the permeate in the art. A limitation of these filters is the inability to adjust the pore size to a diameter small enough to stop, for example, sodium and chloride ions from passing through the filter, which is necessary for the production of drinking water from seawater, i.e., desalination. The production of drinking water from seawater is becoming increasingly popular due to the decreasing amount of sufficiently pure fresh water available. Solution-diffusion filters are crucial in desalination, which is commonly performed by reverse osmosis (RO). The selective layer of RO filters usually consists of thin film composite (TFC) polymer membranes formed by interfacial polymerization methods. The filtration of water through TFC membranes is based on a solution-diffusion mechanism, where water is first molecularly dissolved in the polymer matrix on the side of the higher chemical potential, whereby water diffuses through the polymer into the chemical potential gradient and finally desorbs on the side of the lower chemical potential. To overcome the osmotic pressure involved, a pump is used to drive the filtration process. The rate-limiting step is diffusion through the polymer matrix, which can be improved at the expense of reduced selectivity. Thus, solution-diffusion filters suffer from suboptimal water diffusion rates and therefore require large amounts of energy to purify water.
[0005] Advances in protein engineering and nanotechnology have opened up the possibility of utilizing biomimicry to perform highly selective water treatment. The main driving force behind this approach is the potential to combine high selectivity with high flux, which is not possible with the use of synthetic TFC membranes. The development of filters based on biomimicry has proven problematic due to the limited stability of biological components, such as aquaporins, outside of their natural environment. Thus, various approaches have been explored to produce biomimetic filters stable enough for real-world use. One approach explored to stabilize aquaporins is to deposit supported lipid bilayers (SLBs) or proteoliposomes containing aquaporins onto a porous support. The most common approach to date, judged by scientific outcomes, is based on the insertion of aquaporins into amphiphilic block copolymer (BCP) bilayers. Aquaporins have also been stabilized using other organic molecules, e.g., bolaamphiphiles, and in a two-step method in which amphiphilic peptides were used for initial aquaporin stabilization followed by polymer stabilization.
[0006] US Patent No. 9,943,812 relates to a filtering structure for enhancing stability and durability comprising a porous support in which polymeric membrane structures containing membrane proteins are fixed to each other and to the supporting pore walls via linkers.
[0007] WO 2010 / 040353 relates to a method for producing a membrane or thin fabric for selectively transporting and / or filtering compounds between fluids. The document discloses natural or engineered proteins incorporated into polymer vesicles that bind to the threads to form vesicle-thread complexes.
[0008] WO 2015 / 144724 discloses a filtration membrane comprising a porous support and a layer containing a plurality of vesicles having incorporated therein a transmembrane protein, the vesicles being formed from an amphiphilic block copolymer, the vesicles being covalently linked to each other to form a viscous mass.
[0009] WO 2010 / 091078 discloses a nanoengineered membrane containing polymerized proteoliposomes, which is a bio-nanofusogenic selective membrane using protein-incorporated UV-crosslinkable liposomes with a chemically reactive biocompatible stromal matrix.
[0010] Ji et al., Recent developments in nanofiltration membranes based on nanomaterials, Chinese Journal of Chemical Engineering 2017, 25:1639-1652, is a review of research on nanofiltration membranes containing metal and metal oxide nanoparticles, carbon-based nanomaterials, metal-organic frameworks (MOFS), water channel proteins, and organic micronanoparticles.
[0011] Despite the above mentioned approaches, the commercial potential of nanoscale biomimetic water filtration is still largely unexplored. The main reasons for the limited commercial implementation are the manufacturing difficulties, especially related to the formation of macroscopic defects in the selective layer and the lack of stability required for practical use in membrane designs incorporating aquaporins. Despite the efforts invested in the development of biomimetic water filters through various creative approaches, this research field has therefore not yet been able to deliver real-world performances on par with its predicted potential. Summary of the Invention
[0012] It is a general objective to provide polymeric membrane structures with improved mechanical properties.
[0013] It is a particular object to provide such a polymeric membrane structure that is stable enough to be used in a filtration device.
[0014] These and other objectives are met by the embodiments disclosed herein.
[0015] The invention is defined in the independent claims. Further embodiments of the invention are defined in the dependent claims.
[0016] One aspect of the embodiment relates to a polymeric membrane structure comprising a membrane comprising an integral membrane protein that allows water to pass through, the membrane having a first surface coated with a silica layer.
[0017] Another aspect of the embodiment relates to a filtration device comprising a porous support containing a plurality of pores and the polymeric membrane structure described above.
[0018] A further aspect of the embodiment relates to a method of preparing a water filtrate, the method comprising filtering an aqueous solution through the polymeric membrane structure described above or the filtration device described above to obtain a water filtrate.
[0019] Yet another aspect of the embodiment relates to a method for concentrating a compound dissolved or dispersed in an aqueous solution, the method comprising filtering the aqueous solution through the polymeric membrane structure described above or the filtration device described above to obtain an aqueous filtrate free of the compound and a retentate containing the compound in a higher concentration than the aqueous solution.
[0020] One aspect of the embodiments relates to a method for preparing a polymeric membrane structure, the method comprising contacting a membrane containing an integral membrane protein that allows water to pass through with a silica precursor to form a silica layer coated on a first surface of the membrane.
[0021] Another aspect of the embodiment relates to a method for preparing a filtration device, comprising depositing a membrane comprising an integral membrane protein that allows water to pass on and / or in a porous support, the method also comprising contacting the membrane comprising an integral membrane protein that allows water to pass on and / or in the porous support with a silica precursor to form a silica layer coated on a first surface of the membrane.
[0022] The present invention provides for the stabilization of polymeric membrane structures, such as proteoliposomes, incorporating water-permeable integral membrane proteins to enable the use of these structures in filtration devices and for various filtration applications. The stabilization is achieved by coating the membranes having water-permeable integral membrane proteins with a silica layer, while still maintaining the water-permeable function of the water-permeable integral proteins.
[0023] The embodiments, together with further objects and advantages thereof, may best be understood by reference to the following description taken together with the accompanying drawings, in which: [Brief description of the drawings]
[0024] [Figure 1] Schematic diagram showing silicification of proteoliposomes: After addition of tetraethyl orthosilicate (TEOS), a silica shell is deposited onto proteoliposomes consisting of human aquaporin 4 (hAQP4) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipids. [Figure 2A] 1 is a SANS profile showing the silicification method of hAQP4-containing proteoliposomes. [Figure 2B] CD spectrum of hAQP4 during silicification of proteoliposomes. [Figure 3A] Partially opened silicified hAQP4-containing proteoliposomes with assigned geometric parameters: ti represents the thickness of the inner leaflet lipid headgroups, Dc represents the thickness of the hydrophobic lipid tails from both leaflets, t0 represents the thickness of the outer leaflet lipid headgroups, and tSiO2 represents the thickness of the silica shell. [Figure 3B] FIG. 10 is a comparison of deposited silica volume as a function of time for silicification of liposomes (squares) and proteoliposomes (circles). The solid line shown is a fit to an Avrami-type equation. [Figure 3C] 1 is a schematic diagram of the silicification method. hAQP4-containing proteoliposomes are mixed with the silica precursor TEOS, which forms a silica shell on the outside of the proteoliposomes. [Figure 4A] TEM micrographs of silicified hAQP4-containing POPC proteoliposomes at low magnification: the dark lines indicate the silicified aquaporin-containing lipid bilayer, and the lighter areas surrounded or associated with the aquaporin-containing lipid bilayer indicate silica. [Figure 4B] TEM micrographs of silicified hAQP4-containing POPC proteoliposomes at high magnification: the dark lines indicate the silicified aquaporin-containing lipid bilayer, and the lighter areas surrounded or associated with the aquaporin-containing lipid bilayer indicate silica. [Figure 4C] FIG. 1 shows a STEM micrograph of silicified proteoliposomes in which silica deposits are shown as bright features. [Figure 4D] FIG. 1 shows a STEM micrograph of silicified proteoliposomes in which silica deposits are shown as bright features. [Diagram 5] Scanning transmission electron microscopy-energy dispersive X-ray spectroscopy (STEM-EDX) imaging was performed on dried silicified vesicles containing aquaporins. Elemental maps were obtained for sulfur (present only in aquaporins), silicon, carbon, phosphorus (present only in POPC lipids) and oxygen. Elemental maps of the individual elements pinpointed the location of these elements in the silicified vesicles containing aquaporins. All of these elements were shown to be preferentially located in the bilayer and its associated silica coating. A STEM high angle annular dark field (HAADF) micrograph of the same sample area is inserted at the top left position. [Figure 6] Energy-filtered transmission electron microscopy (EFTEM) was used as a complementary method to STEM-EDX for the localization of specific elements in dried silicified vesicles containing aquaporins. EFTEM, due to its increased sensitivity to lighter elements, was able to map both nitrogen and hydrogen in addition to the elements mapped by STEM-EDX. EFTEM confirmed the STEM-EDX results in that all of the relevant elements were preferentially located in the bilayer and its associated silica coating. A plasmon-filtered EFTEM image of the same sample area is inserted at the top left position. [Figure 7]1 is a schematic diagram of a filtration device according to one embodiment. [Figure 8] FIG. 2 is a schematic diagram of a filtration device according to another embodiment. [Figure 9] FIG. 2 is a schematic diagram of a filtration device according to a further embodiment. [Figure 10] 4 is a schematic diagram of a filtration device according to yet another embodiment. [Figure 11] Time-resolved dynamic light scattering (DLS) was used to study the aggregation behavior of liposomes and proteoliposomes during the silicification process. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0025] In general, all terms used herein should be interpreted according to their ordinary meaning in the relevant technical field unless a different meaning is clearly given and / or implied from the context in which they are used. All references to elements, apparatus, components, means, steps, etc., should be openly interpreted as referring to at least one example of the element, apparatus, component, means, step, etc., unless otherwise specified. The steps of any method disclosed herein need not be performed in the order disclosed, unless a step is explicitly described as following or preceding another step, and / or it is implicit that a step must follow or precede another step. Any feature of any of the embodiments disclosed herein may be applied to any other embodiment, as appropriate. Similarly, any advantage of any embodiment may be applied to any other embodiment, and vice versa. Other objects, features, and advantages of the accompanying embodiments will become apparent from the following description.
[0026] The present invention relates generally to polymeric membrane structures and filtration devices including such polymeric membrane structures and their use, for example, in water filtration.
[0027] The present invention is based on the finding that the stability of polymeric membrane structures incorporating integral membrane proteins (IMPs), such as transmembrane proteins (TPs), can be increased by coating the surface of the membrane with a silica layer. Such surface coating with silica can be performed while still maintaining the functionality of the IMPs or TPs, and preferably the native conformation of the IMPs and TPs. Thus, silicification constitutes an efficient method to achieve sufficient stability in biomimetic membranes and filters, allowing the real implementation of said polymeric membrane structures in practical applications, for example in filtration devices and water filtration.
[0028] Accordingly, the present invention relates to a polymeric membrane structure comprising a membrane that includes an IMP or TP that allows water to pass through and is coated with a silica layer on a first surface of the membrane.
[0029] 1 shows a schematic diagram of one such polymeric membrane structure in the form of a vesicle 2 (also referred to in the art as a protein-containing liposome or proteoliposome 2, which uses a water-permeable IMP 1) of a lipid bilayer membrane 3 that contains a water-permeable IMP 1. The proteoliposome 2 has, in this example, a silica layer or shell 4 on its outer surface.
[0030] The membrane 3 of the polymer membrane structure 2 is preferably a bilayer membrane 3, i.e. a bilayer membrane 3 comprising two layers. The layers of the bilayer membrane 3 are preferably composed of amphiphilic molecules, i.e. molecules having a hydrophilic part and a lipophilic, i.e. hydrophobic part.
[0031] In certain embodiments, the membrane 3 of the polymeric membrane structure 2 is a lipid bilayer membrane 3. Thus, the amphiphilic molecules are amphiphilic lipids. Non-limiting but illustrative examples of such amphiphilic lipids include phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol, cardiolipin, cholesterol, sphingomyelin, asolectin, diphytanoylphosphatidylcholine (DPhPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-dihex ... dilauroylphosphatidylcholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG), 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (14:0 lyso-PC such as 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 lyso-PC), 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (16:0 lyso-PE) or 1-oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (18:1 Lyso-PE such as 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dierucoyl-sn-glycero-3-phosphate (DEPA), 1,2-erucoyl-sn-glycero-3-phosphocholine (DEPC), 1,2-dierucoyl-sn-alicero-3-phosphoethanolamine (DEPE), 1,2-linoleoyl-sn-glycero-3-phosphocholine (DLOPC), 1,2-dilauroyl-sn-glycero-3-phosphate (DLPA), 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE), 1,2-dilauro ...2-Dilauroyl-sn-glycero-3-phosphoserine (DLPS), 1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA), 1,2-dimyristoyl-sn-glycero-3-phosphoserine (DMPS), 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), 1,2-oleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine ( DOPE), 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS), 1,2-dipalmitoyl-sn-glycero-3-phosphate (DPPA), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 1,2-dipalmitoyl-sn-glycerco-3-phosphoserine (DPPS), 1,2-distearoyl-sn-glycero-3-phosphate (DSPA), 1,2-distearoyl-sn-glycero 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-diostearoyl-sn-glycero-3-phosphoethanolamine (DSPE), 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (MSPC), 1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine (PMPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC ... These include glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (PSPC), 1-stearoyl-2-myristoyl-sn-glycero-3-phosphocholine (SMPC), 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine (SPPC), and mixtures thereof. Currently, the preferred example of an amphiphilic lipid is POPC.
[0032] Amphipathic lipids may also or alternatively be selected from natural sources, such as lipids from cell membranes and / or organelles, such as the nucleus, mitochondria, chloroplasts, endoplasmic reticulum, Golgi apparatus, and lysosomes.
[0033] In fact, the membrane of the polymeric membrane structure may actually be an intact cell membrane, such as a yeast or bacterial cell, that contains water-permeable IMPs and is coated with a silica layer. Moreover, organelles containing such water-permeable IMPs can be coated with a silica layer to form the polymeric membrane structure according to the present invention. In these cases, the membrane of the cell or organelle typically contains other membrane proteins besides the water-permeable IMPs.
[0034] Alternatively or additionally, the membrane 3 may comprise a cross-linkable lipid, i.e. an amphiphilic lipid having a cross-linkable chemical structure in the hydrophobic and / or hydrophilic part of the amphiphilic lipid molecule. Examples of such cross-linkable lipids are disclosed in WO 2010 / 091078 and include, inter alia, 1-palmitoyl-2-(10Z,12Z-tricosdiynoyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-(10Z,12Z-tricosdiynoyl)-sn-glycero-3-phosphoethanolamine, 1,2-di-(10Z,12Z-tricosdiynoyl)-sn-glycero-3-phosphocholine and 1-2-(10Z,12Z-tricosdiynoyl)-sn-glycero-3-phosphoethanolamine. The cross-linkable lipid is preferably UV cross-linkable, i.e. cross-linking is induced by UV exposure.
[0035] The membrane may comprise a single type or species of amphipathic lipid or a mixture of multiple, ie, at least two different types or species of amphipathic lipids.
[0036] Alternatively or additionally, the amphiphilic molecules of the membrane 3 may be amphiphilic copolymers, such as amphiphilic AB, ABA and / or ABC block copolymers. Illustrative, but non-limiting examples of such amphiphilic copolymers include poly(methyloxazoline)-poly(dimethylsiloxane)-poly(methyloxazoline) (PMOXA-PDMS-PMOXA), poly(2-ethyl-2-oxazoline)-b-poly(dimethylsiloxane)-b-poly(2-ethyl-2-oxazoline) (PEtOz-PDMS-PEtOz) and mixtures thereof. More generally, amphiphilic copolymers include (poly)2-C 1-3 At least one hydrophilic block comprising an alkyl-2-oxazoline and at least one hydrophobic block comprising PDMS, e.g., ((poly)2-C 1-3 Alkyl-2-oxazoline a -PDMS b -((Poly)2-C 1-3 Alkyl-2-oxazoline a wherein each a is independently a number from 5 to 100, and b is a number from 5 to 140. In the case of the membrane 3 having an amphiphilic copolymer, the polymer membrane structure 2 is a proteopolymersome.
[0037] The polymeric membrane structure 2 is preferably in the form of a vesicle, proteoliposome or proteopolymersome 2 as shown in Figure 1. In such a case, the membrane 3 is a proteoliposome or proteopolymersome 2, the outer surface of which is coated with a silica layer 4.
[0038] In another embodiment, the polymeric membrane structure 2 is a substantially flat or 2D membrane structure having the membrane 3 as a substantially flat or planar structure. The silica layer 4 is then applied to one of the surfaces of the flat or planar membrane 3.
[0039] In one embodiment, the water channel IMP1 incorporated in the membrane 3 of the polymeric membrane structure 2 is aquaporin 1.
[0040] Aquaporins, also called water channels, are IMPs derived from a larger family of major endogenous proteins that form pores in the membranes of biological cells and primarily facilitate the transport of water between cells. The cell membranes of a variety of different bacterial, fungal, animal and plant cells contain aquaporins, through which water can flow more rapidly into and out of the cell than by diffusing through the phospholipid bilayer. Aquaporins have six transmembrane alpha helical domains with both the carboxylate and amino termini on the cytoplasmic side. Two hydrophobic loops contain the conserved asparagine-proline-alanine NPA motif.
[0041] In one embodiment, the aquaporin is selected from the group consisting of human aquaporin (hAQP), bovine aquaporin (bAQP), fish aquaporin, yeast aquaporin, plant aquaporin and bacterial aquaporin, and mixtures thereof.
[0042] There are 13 human aquaporins, which can be divided into three subgroups: water-selective (orthodox) aquaporins (hAQP0, hAQP1, hAQP2, hAPQ4, hAPQ5, hAQP6, hAQP8), which transport only water; aquaglyceroporins (hAQP3, hAQP7, hAQP9, hAQP10), which transport small uncharged solutes such as glycerol in addition to water; and superaquaporins (hAQP11, hAQP12), whose transport properties remain to be further elucidated. In one embodiment, the hAQP is selected from the group consisting of hAQP0, hAQP1, hAQP2, hAQP3, hAQP4, hAQP5, hAQP6, hAQP7, hAQP8, hAQP9, hAQP10, hAQP11 and hAQP12, preferably selected from the group consisting of hAQP0, hAQP1, hAQP2, hAQP4, hAQP5, hAQP6 and hAQP8, i.e., water-selective human aquaporins, more preferably hAPQ4.
[0043] A preferred bovine aquaporin is bAQP1, and a preferred fish aquaporin is cpAQP1aa. A preferred example of a yeast aquaporin is Aqy1, and a suitable bacterial aquaporin is AqpZ. Examples of plant aquaporins that can be used include SoPIP2;1, AtTIP2;1, and AtPIP2;4.
[0044] In one embodiment, the membrane 3 comprises a single type or species of aquaporin 1. In another embodiment, the membrane 3 comprises multiple types or species of aquaporin 1.
[0045] In one embodiment, the silica layer 4 has an average thickness selected within the range of 0.1 to 1000 nm, preferably 1 to 100 nm, more preferably 1 to 10 nm. In a particular embodiment, the silica layer has an average thickness within the range of 2 to 6 nm, preferably 3 to 5 nm, more preferably 3 to 4 nm.
[0046] As previously described herein, a membrane 3 including a water permeable IMP1 can be coated with a silica layer 4 as disclosed herein while maintaining the water permeable function of the water permeable IMP1. Thus, the water channel IMP1 remains functional in the polymeric membrane structure 2 in that it is capable of transporting water through the membrane 3 in the presence of the silica layer 4. Thus, in certain embodiments, the silica layer 4 does not prevent or block the water permeable or transport function of the water permeable IMP1.
[0047] In one embodiment, the silica layer 4 is a functionalized silica layer 4. Thus, the silica layer 4 comprises functional molecules that can exert a desired function on the polymeric membrane structure 2. One example of such a function is a linking function (binding function). Thus, the functional molecules of the silica layer 4 can be used to fix, attach or link, for example covalently bond, the polymeric membrane structure 2 to a support.
[0048] In certain embodiments, the functionalized silica layer 4 comprises a silane, such as fluoroalkylsilane (FAS), an alkoxysilane, such as hexamethyldisilazane (HMDZ), or a combination thereof. These functional molecules can then be used to covalently bond the polymeric membrane structure 2 to a support using silane chemistry. For example, FAS can be used to form a covalent bond between the silica layer and an alumina support, or a support having an alumina coating.
[0049] The polymeric membrane structure 2 can be prepared by a process that includes contacting a membrane 3 containing a water-permeable IMP 1 with a silica precursor to form a silica layer 4 coated on a first surface of the membrane 3.
[0050] In one embodiment, the silica precursor is selected from the group consisting of silicon alkoxides, silanes, silicates, silanols, silazanes, N-sec-butyl(trimethylsilyl)amine, and combinations thereof.
[0051] In one embodiment, the silicon alkoxide is selected from the group consisting of tetramethylorthosilicate (TMOS), tetraethylorthosilicate (TEOS), tetrapropylorthosilicate, tetrabutylorthosilicate, methyltriethoxysiloxane (MTES), dimethyldiethoxysiloxane (DMDES), tetrakis(glycerol)orthosilicate (TGS), tetrakis-(2-hydroxyethyl)-orthosilicate (THEOS), and combinations thereof.
[0052] In one embodiment, the silane is allyltrimethoxysilane, (3-aminopropyl)triethoxysilane, butyltrichlorosilane, chloropentamethyldisilane, 1,2-dichlorotetramethyldisilane, diethoxydiphenylsilane, [3-(diethylamino)propyl]trimethoxysilane, dimethoxydimethylsilane, dimethoxy(methyl)octylsilane, (3-glycidyloxypropyl)trimethoxysilane, hexamethyldisilane, isobutyl(trimethoxy)silane, methyltrichlorosilane, pentamethyldisilane , n-propyltriethoxysilane, tetraethylsilane, 1,1,2,2-tetramethyldisilane, tetramethylsilane, triethoxymethylsilane, triethoxyoctylsilane, trimethoxyphenylsilane, triethoxyphenylsilane, triethoxyvinylsilane, trimethoxymethylsilane, gamma-aminopropyltriethoxysilane, silicon tetrachloride (tetrachlorosilane), silicon tetrabromide (tetrabromidosilane), gamma-aminopropylsilanetriol (APSTOL), and combinations thereof.
[0053] In one embodiment, the silicate is sodium silicate (water glass).
[0054] In one embodiment, the silanol is selected from the group consisting of tris(tert-pentoxy)silanol, tris(tert-butoxy)silanol, and combinations thereof.
[0055] In one embodiment, the silica precursor is TEOS.
[0056] In one embodiment, the membrane 3 is contacted with the silica precursor in a buffer solution containing a buffering agent. Non-limiting but illustrative examples of buffering agents that can be used in the buffer solution include tris(hydroxymethyl)aminomethane (Tris), phosphate buffered saline (PBS), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid (TES), 2-(N-morpholino)ethanesulfonic acid (MES) and 3-(N-morpholino)propanesulfonic acid (MOPS). One example of a suitable buffering agent is Tris. The buffer solution can then be an aqueous Tris-HCl solution.
[0057] In one embodiment, the buffer comprises a salt to adjust or set the ionic strength of the buffer. Non-limiting but illustrative examples of salts that can be used include chloride salts, sulfate salts, carbonate salts and mixtures thereof. Chloride salts that can be used according to the embodiment include NaCl, KCl, CaCl2 and MgCl2. MgSO4 and CaSO4 are suitable examples of sulfate salts, while Na2CO3 is a preferred example of carbonate salts.
[0058] The pH of the buffer solution is determined at least in part based on one or more buffering agents. The pH of the buffer solution can be acidic, i.e., less than 7, neutral, i.e., about 7, or basic, i.e., greater than 7. The pH of the buffer solution affects the properties of the silica layer 4 formed. For example, an acidic pH, such as pH 2, produces a denser silica layer 4 compared to neutral or basic buffer solutions. Correspondingly, the formation of the silica layer in slightly basic conditions (pH 8) proceeded by an initial placement of silicic acid around the membrane 3, followed by densification.
[0059] The water permeable IMP 1 in the water selective membrane 3 effectively precluded certain reagents used in the silicification process from entering or passing through the membrane containing the water permeable IMP 1. This was an important and highly unexpected advantage of the present invention, as the reagents would otherwise adversely affect the membrane 3 and polymeric membrane structure 2 and potentially become contaminant in the filtrate passing through the membrane 3.
[0060] Polymeric membrane structures 2 of embodiments, such as those prepared according to the methods described above, may include a thin layer of water between the membrane 3 and the silica layer 4. Such a water layer may be encapsulated during the preparation method and typically has a thickness in the nm or sub-nm range.
[0061] In one embodiment of the method for producing silica-coated proteoliposomes 2 containing aquaporin 1, phosphatidylcholine lipids, such as 1-palmitoyl-2-oleoyl-sn-glycerophosphatidylcholine (POPC), are first uniformly dispersed in a buffered aqueous solution, which may contain, for example, either Tris or PBS to set the pH and a salt such as NaCl to set the ionic strength. The lipids may or may not be dissolved in a solvent less polar than water, such as chloroform (CHCl3), and the CHCl3 may then be removed before dispersion in the buffered aqueous solution. A mild detergent, such as n-octyl-β-D-glucoside (β-OG) or n-nonyl-β-D-glucoside (β-NG), may be added to solubilize the liposomes. Purified aquaporins stabilized with a mild detergent, such as β-OG or β-NG, are added to the liposome mixture. The detergent is then preferably removed from the mixture, for example using polystyrene bead adsorption followed by removal, or dialysis, for example using cellulose acetate dialysis membranes with a molecular cut-off of 1000 Da or 2000 Da. This procedure results in multilamellar and polydisperse vesicles 2 containing aquaporin 1.
[0062] In one embodiment, vesicles 2 may be further treated prior to silicification to reduce the degree of multilamellarity and polydispersity. For example, vesicles 2 containing aquaporin 1 may be extruded through the pores of a polycarbonate extrusion membrane or a nylon centrifugal filter having a diameter in the range of 30 nm to 1000 nm to reduce the degree of multilamellarity and polydispersity.
[0063] A layer 4 of silica ranging in thickness from 0.1 nm to 1000 nm can then be formed on the vesicles containing aquaporin 1. In an exemplary silica coating procedure, a silicon alkoxide such as TEOS, or cation-exchanged sodium silicate (water glass) is added to the vesicles 2 containing aquaporin 1. The silicon alkoxide can be pre-hydrolyzed in a solution without vesicles 2 before being added to the vesicles 2 containing aquaporin 1, or added directly to the vesicles 2 containing aquaporin 1. Hydrolysis of the silicon alkoxide leads to the formation of orthosilicic acid as well as silicon alkoxide Q1, Q2 and Q3 species, where 0, 1, 2 and 3 alkoxide groups are covalently bonded to silicon due to incomplete hydrolysis of the silicon alkoxide. Condensation of these species in the presence of the vesicles 2 containing aquaporin 1 results in the formation of a layer 4 of silica on the outside of the vesicles 2 containing aquaporin 1. Silica-coated vesicles 2 containing aquaporin 1 may aggregate during condensation, which may result in the formation of a second silica coating on the aggregates ranging in thickness from 0.1 nm to 300 nm.
[0064] In one embodiment, the formation of the silica layer 4 may be followed by surface modification of the vesicles 2 containing aquaporin 1. In an exemplary procedure, functional groups, such as silanes, are introduced into the silica layer 4 of the vesicles 2 containing aquaporin 1. In an exemplary procedure, the coated vesicles 2 containing aquaporin 1 are placed in hexane containing 1% (volume / volume) hexamethyldisilazane (HMDZ). The available silanol groups (Si-OH) on the silica surface are partially replaced with methylated groups. Other examples of silanes that may be used include, but are not limited to, fluoroalkylsilanes (FAS) and alkoxysilanes.
[0065] Another aspect of the present invention relates to a filtration device 5. See Figures 7 to 9. The filtration device 5 includes a porous support 6 including a plurality of pores 7 and a polymer membrane structure 2 according to an embodiment.
[0066] In one embodiment, the polymer membrane structure 2 is provided on the surface of a porous support 6. In an exemplary embodiment, vesicles 2 containing a water-permeable IMP are introduced into a porous support 6 having surface-accessible pores 7, e.g., with pore widths in the range of 0.5-50 nm. The vesicles 2 are adsorbed onto the porous support 6 and collapse into a supported lipid bilayer containing a single pore-piercing aquaporin or a stack of supported lipid bilayers containing multiple aquaporins.
[0067] Alternatively or additionally, the polymer membrane structure 2 is provided in the pores 7 of the porous support 6. Depending on the material of the porous support 6, the pores 7 may be regular or irregular, have clearly defined pores 7 with a specific diameter, such as 50 nm to 5000 nm, or may be vaguely defined by a network structure. The pore width may be the same throughout the thickness of the porous support 6, or may be wider at one end of the porous support 6 compared to the other end. The pore width may also vary throughout the porous support 6 independent of the position in the thickness. Vesicles 2 containing IMP1 that are permeable to water can be introduced into the pores 7 by placing the porous support 6 in a solution of vesicles 2. An external force introduced, for example, by applying pressure or suction, may or may not be used to achieve successful introduction. In one example, the porous support 6 is placed in a filter holder connected to a syringe pump via a tube.
[0068] The porous support 6 together with the polymeric membrane structure 2 form a filtration device 5 or filter that can be used to filter various liquids as further disclosed herein. Coating the membrane 3 with a silica layer 4 increases the stability of the polymeric membrane structure 2 and the IMP 1 which allows water to pass through, allowing them to be used in such filtration operations and still have a sufficient operational or shelf life. This is otherwise a significant problem of prior art biomimetic filtration devices.
[0069] The porous support 6 is any support that is semi-permeable, i.e., allows filtrate to pass through the porous support 6 and the polymeric membrane structure 2 present therein or thereon. The porous structure 6 supports the polymeric membrane structure 2, but should also be durable to the operation or method to be performed, such as being able to withstand a particular pressure or chemical environment. The porous support can take any shape, including flat membranes, circular membranes, etc., to suit the operation or method to be performed.
[0070] The porous support 6, in one embodiment, can be made from a polymer, a metal, an oxide of a metal, silicon dioxide, glass fiber, or a mixture thereof. Non-limiting but illustrative examples of polymeric materials for the porous support 6 include polysulfone, polyethersulfone, polyphenylsulfone, polyetherethersulfone, polyetherketone, polyetheretherketone, polyphenylene ether, polydiphenylphenylene ether, cellulose, polyvinylene cellulose acetate, cellulose diacetate, cellulose triacetate, cellulose nitrate, polyphenylene sulfide, nitrocellulose, acetylated methylcellulose, polyacrylonitrile, polyvinyl alcohol, polycarbonate, organosiloxane carbonate, polyester carbonate, organopolysiloxane, polyethylene oxide, polyamide, polyimide, polyamideimide, polybenzimidazole, polyolefin, polyacrylonitrile, nylon, and mixtures thereof. Non-limiting, but illustrative examples of metal (oxide) materials for the porous support 6 include aluminum, aluminum oxide (alumina), titanium, titanium dioxide, zirconium, zirconium dioxide (zirconia), iron, iron oxide, and mixtures thereof.
[0071] The polymeric membrane structure 2 may be provided on the porous support 6 and / or within the pores 7 of the porous support 6 in the form of a single layer, as shown in FIG. 8, or may comprise a thicker layer of the polymeric membrane structure 2 as shown in FIG. 7, which typically comprises multiple layers of the polymeric membrane structure 2.
[0072] 10 shows an embodiment of a filtration device 5 in which a membrane 3 containing an IMP 1 through which water passes is in the form of a planar structure deposited on a porous support 6 and contains pores 7. The face of the membrane 3 opposite to that facing the porous support 6 is coated with a silica layer 4.
[0073] When the silica layer 4 of the polymeric membrane structure 2 has functional groups as described herein above, the functionalized silica layer's functionalized groups may link, such as by covalent bonds, the polymeric membrane structure 2 to the porous support 6. For example, the functional groups may fix, attach and anchor the polymeric membrane structure 2 to the walls of the pores 7 of the porous support 6 and / or to the top surface of the porous support 6.
[0074] In one embodiment, the polymeric membrane structure 2 is coated with a silica layer 4 before being deposited on and / or in the porous support 6 of the filtration device 5. In another embodiment, the membrane 3 containing the IMPs 2, which allow the passage of water, for example in the form of proteoliposomes 2, is first deposited on and / or in the porous support 6, and then a silicification process is carried out to coat the proteoliposomes 2.
[0075] In this latter embodiment, a method for preparing a filtration device 5 includes depositing a membrane 3, e.g., proteoliposomes 2, comprising a water-permeable IMP1 on and / or within a porous support 6, and contacting the membrane 3 comprising the water-permeable IMP1 deposited on and / or within the porous support 6 with a silica precursor to form a silica layer 4 coated on a first surface of the membrane 3.
[0076] In one embodiment, the membrane 3, such as in the form of proteoliposomes 2, may be fixed or attached to the porous support 6 prior to the silicification method. In such an embodiment, the proteoliposomes 2 may be connected and anchored to the upper surface of the porous support 6 and / or to the walls within the pores 7 of the porous support 6. The attachment and fixation may be achieved by a linker such as those disclosed in US Pat. No. 9,943,812. Such linkers may be selected from the group consisting of primary amine crosslinkers, sulfhydryl crosslinkers, carbohydrate crosslinkers, carboxyl crosslinkers and photoreactive crosslinkers. The primary amine crosslinkers may be imidoesters, N-hydroxysuccinimide esters, or glutaraldehyde, and the sulfhydryl crosslinkers may be maleimides, haloacetyls, or pyridyl disulfides. The carbohydrate reactive crosslinkers may be 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride or 1,3-dicyclohexylcarbodiimide, and the photoreactive crosslinkers may be aryl azides or diazirines.
[0077] The polymer membrane structure 2 and the filtration device 5 of the embodiment can be used for water purification to prepare a water filtrate. In such an application, an aqueous solution is filtered through the polymer membrane structure 2 or the filtration device 5 to obtain a water filtrate.
[0078] The aqueous solution may be, for example, contaminated or polluted water, salt water, or indeed any aqueous solution that is to be filtered or purified by removing contaminants or contamination, such as salt ions, from the water to produce a pure water filtrate.
[0079] The polymeric membrane structure 2 and filtration device 5 of the embodiments can also be used in a method for concentrating a compound dissolved or dispersed in an aqueous solution, which includes filtering the aqueous solution through the polymeric membrane structure 2 or filtration device 5 to obtain an aqueous filtrate that does not contain the compound, and a retentate, also referred to in the art as a retentate feed, that contains the compound in a higher concentration than the aqueous solution.
[0080] Thus, filtering an aqueous solution through the polymeric membrane structure 2 or filtration device 5 provides an aqueous filtrate, enriching the retentate with respect to compounds dissolved or dispersed therein.
[0081] Thus, once the polymeric membrane structure 2 comprising the water permeable IMP 1 has been deposited and, optionally, immobilized on and / or within the porous support 6, the resulting filtration device 5 may be useful in methods of water filtration to provide a pure water filtrate. This may be done using methods such as forward osmosis, reverse osmosis or pressure retarded osmosis. The same configuration may also be used to concentrate a solution of a target molecule by removing excess water from the solution containing the target molecule.
[0082] Aquaporin 1-containing water-translocating IMP1-containing membranes 3 or vesicles 2 can be formed by incorporating water-translocating IMP1 into membranes 3 or vesicles 2 by a method called reconstitution, which generally involves solubilizing water-translocating IMP1 by using specific detergents, which aid in the removal of water-translocating IMP1 from their source membranes while maintaining the integrity and biological function of water-translocating IMP1. Once solubilized, water-translocating IMP1 can be reinserted into the target membrane 3 or vesicle 2 of interest.
[0083] Membranes 3 or vesicles 2 containing IMP1 that allow water to pass through can also be formed by converting source membranes into membranes 3 and vesicles 2, thus preserving as much of their natural environment as possible. Such conversion is performed by extruding the source membrane through a porous filter with a defined pore size, thus reducing the source membrane into small fragments and vesicles 2 of a specific size. EXAMPLES
[0084] Working Example This example discloses a method for coating proteoliposomes with a thin layer of silica. More specifically, the passive water transporter human aquaporin 4 (hAQP4) was reconstituted in phosphatidylcholine (POPC) liposomes, which were then coated with a thin layer of silica. The silicification process of proteoliposomes was monitored in detail to elucidate the mechanism of silica shell growth. The secondary structure of hAQP4 was also monitored throughout the silicification process to provide an assessment of protein suitability in this type of silicification.
[0085] hAQP4 production in Pichia pastoris and protein purification Protein production in P. pastoris was performed according to a protocol based on the production of genetically optimized hAQP4 [Nyblom et al., Protein Expr. Purif. 2007, 56(1):110-120], resulting in a yield of more than 300 g wet cells per L of culture. Cells were harvested by centrifugation (6000 g, 45 min, 4° C.) and stored at −20° C. For membrane preparation, 85 g cells were thawed at 4° C. and resuspended in 200 mL of disruption buffer (50 mM Tris-HCl pH 7.4 (Sigma-Aldrich) containing 150 mM NaCl (Sigma-Aldrich), 1 mM 2-mercaptoethanol (Fluka AG), and two EDTA-free cOmplete protease inhibitor cocktail tablets (Roche)). Cells were disrupted with 0.5 mm glass beads (Scientific industries) using a Bead Beater (Bio Spec) and ground for 12 × 30 s with 60 s cooling between runs. Undisrupted cells were harvested by centrifugation (6000 g, 10 min, 4°C) and crude membranes were then recovered from the supernatant by ultracentrifugation (19000 g, 60 min, 4°C). The resulting membranes were washed with urea buffer (4 M urea, 5 mM Tris-HCl pH 7.4, 2 mM EDTA, 2 mM EGTA) using a homogenizer and centrifuged again (19000 g, 60 min, 4°C). The resulting pellet was homogenized and subjected to a sodium hydroxide wash (20 mM NaOH) and a subsequent centrifugation step (19000 g, 60 min, 4°C). A final wash was performed to remove traces of NaOH by homogenizing the membranes in membrane resuspension buffer (20 mM Tris-HCl pH 7.4, 250 mM NaCl, 1 mM 2-mercaptoethanol, 10% (wt / vol) glycerol). After a final centrifugation (19000 g, 60 min, 4° C.), the washed membrane pellet was resuspended in resuspension buffer at a concentration of approximately 400 mg membrane / ml.
[0086] Membrane solubilization of hAQP4 was performed by mixing membranes with solubilization buffer (25 mM Tris-HCl pH 7.4, 250 mM NaCl, 1 mM 2-mercaptoethanol, 10% (wt / vol) glycerol, 400 mM n-octyl-β-glucopyranoside (OG, analytical grade, Anatrace)) supplemented with EDTA-free protease inhibitor cocktail tablets in a 1:1 volume ratio. After gentle stirring for 90 min at 4 °C, insolubilized material was removed by ultracentrifugation (19000 g, 60 min, 4 °C) and imidazole was added to the supernatant to correspond to a final concentration of imidazole of 50 mM.
[0087] For purification of hAQP4, the supernatant was loaded onto a pre-equilibrated 5 ml Ni-NTA HisTrap HP column (GE Healthcare) and circulated for at least 2 h. Prior to loading the supernatant, the column was equilibrated for 3 CV (20 mM Tris-HCl pH 7.4, 300 mM NaCl, 10% glycerol, 40 mM OG, 50 mM imidazole). Non-specifically bound proteins were removed by washing the column matrix with 20 ml of equilibration buffer. Proteins were eluted with 20 ml of elution buffer (20 mM Tris-HCl pH 7.4, 300 mM NaCl, 10% glycerol, 40 mM OG, 300 mM imidazole) and collected in fractions. Protein fractions were analyzed using SDS-PAGE and protein-containing fractions were pooled together. Subsequent buffer exchange into storage buffer (25 mM citrate pH 6.0, 50 mM NaCl, 5% (wt / vol) glycerol, 40 mM OG, 2 mM DTT) was then performed immediately. Finally, hAQP4 was concentrated to a final concentration of 9.7 mg / ml using a 50 kDa cutoff concentrator (Merck Millipore) and stored at -80°C.
[0088] Preparation of proteoliposomes Proteoliposomes were formed from POPC liposomes and purified hAQP4 by a reconstitution method. Chloroform (Sigma-Aldrich) containing POPC (Avanti Polar Lipids Inc.) was rotary evaporated at 40 °C for 3 h, followed by removal of residual chloroform under nitrogen. Lipid films were prepared at 10 mg ml -1 The lipids were resuspended in reconstitution buffer (50 mM Tris-HCl, 50 mM NaCl, pH 8.0) at a concentration of 4 mg ml and prepared in DO (99.8 atom % D, Sigma-Aldrich) for the SANS experiments (pH 8.4) and in Milli-Q water for the remaining experiments. -1 For 1 ml of proteoliposomes, use 10 mg ml -1 400 μl of reconstitution buffer containing POPC was mixed with 30 μl of 1 M NaCl (Sigma-Aldrich), 30 μl of 1 M Tris-HCl pH 8 (Sigma-Aldrich), and 430 μl of Milli-Q water. 99 μl of 10% (weight / volume) n-octyl-β-D-glucoside was then added with mixing, followed by incubation for 5 min. 9.7 mg ml -1 of purified hAQP4 was added in an amount resulting in a final protein-to-lipid ratio (PLR) of one hAQP4 to six POPC lipids by mass (1:6) for CD measurements and 1:50 for the remaining experiments. The solution was gently mixed and incubated for 10 min at 20 °C. Biobeads SM2 adsorbent (Bio-Rad laboratories) was equilibrated with reconstitution buffer and then added at a wet fraction of 30% (weight / volume) of the sample volume, followed by incubation for 6–10 h at 20 °C on a rotating table in the dark. Biobeads were removed from the samples by centrifugation at 11000 rpm through 0.2 μm spin column filters (WVR) before use.
[0089] Characterization of proteoliposomes by DLS DLS analysis was performed using disposable UVette® cuvettes (Eppendorf) on a Malvern Zetasizer Nano ZS (Malvern) instrument at a fixed detection angle of 173°, with a concentration of 0.05 mg ml -1 Liposome and proteoliposome samples containing 150 μl of lipid were run at 20° C. and data presented are the average from three replicates performed in succession.
[0090] Silicification of proteoliposomes For all experiments except time-resolved DLS and stopped-flow light scattering, 4 mg / ml -1 Silicated liposomes and proteoliposomes were formed using 7.6 μl of tetraethyl orthosilicate (TEOS, 98%, Sigma-Aldrich) added to 800 μl of reconstitution buffer containing 2 mg ml of liposomes and proteoliposomes, and 3.8 μl of TEOS was added to 2 mg ml of reconstitution buffer. -1 The liposomes and proteoliposomes were added to 800 μl of reconstitution buffer. Siliconization was performed in glass vials without stirring at 25 °C for 4 to 16 h in all cases except for the in situ SANS siliconization kinetics experiments.
[0091] Characterization by TEM, STEM, SANS, DLS, stopped-flow light scattering and CD For transmission electron microscopy (TEM) analysis, 4 mg / ml -1 A 2 μl drop of reconstitution buffer containing silicified liposomes and proteoliposomes was placed on a Lacey carbon 300 mesh copper grid (Ted Pella Inc.) and allowed to dry in ambient air. TEM analysis was performed using an FEI Titan 80-300 operated at 300 kV and an FEI Tecnai TF20 operated at 200 kV. Samples for scanning TEM (STEM) were prepared in the same way as for TEM, and STEM analysis was performed using an FEI Titan 80-300 operated at 300 kV.
[0092] Small-angle neutron scattering (SANS) experiments were performed on the D11 instrument at ILL (Institut Laue-Langevin, Grenoble, France) and on the KWS-1 instrument at FRMII (Research neutron source Heinz-Maier Leibnitz, Garching, Germany).
[0093] In FRMII, a narrow quartz cell was used. No rotation was applied. 4 mg / ml -1 Non-silicified and silicified samples were prepared in both Milli-Q water and D2O. The samples were contrast-matched blended with silica at SLD 3.47 and silicon at SLD 2.07. They were studied as is and also "kinetic" studies were performed analyzing proteoliposome samples before, during and after silicification. λ=7Å was used. Detectors were positioned at 1.5m, 8m and 20m to span a wide q range with good overlap between data sets. Data were reduced and modelled using QtiKWS software.
[0094] At the ILL, we used Hellma Analytics 120-QS quartz cells with a 2 mm optical path. They were mounted in a motorized holder that rotated the samples 5.5 times per minute to prevent settling during the silicification process. -1 A sample of proteoliposomes in D2O was diluted to be contrast-matched to silica with an SLD of 3.47. Pre-silicified proteoliposomes and methods of silicification of proteoliposomes were studied. λ=5Å was used to obtain the highest possible intensity. Detectors were positioned at 1.4m, 8m, and 39m to span a wide q range with good overlap between data sets. The temperature was 25°C for both SANS experiments. Data were reduced using BerSANS software [Keiderling, Appl. Phys. A-Mater. Sci. Process 2002, 74:S1455-S1457], while data were modeled using QtiKWS software.
[0095] Disposable UVette® cuvettes (Eppendorf) were used to measure 2 mg / ml at a fixed detection angle of 173° in a Malvern Zetasizer Nano ZS (Malvern) instrument. -1 Time-resolved DLS silicification analysis was performed on 150 μl of liposome and proteoliposome samples containing 2 mg ml lipid. Following the initial DLS recording, -1 3.8 μl of TEOS was added to 800 μl of reconstitution buffer containing liposomes and proteoliposomes. 150 μl samples were analyzed by DLS every 30 min, at which point the samples were returned to the siliconized vials. The temperature was 20° C. and the data presented are the average from three replicates performed consecutively.
[0096] 2mgml -1 Time-resolved stopped-flow light scattering experiments were performed by rapidly mixing reconstitution buffer (50 mM Tris-HCl, 50 mM NaCl, pH 8.0) containing silicified samples of liposomes and proteoliposomes with a hyperosmotic solution (reconstitution buffer containing 300 mM sucrose). Following an initial recording, 2 mg ml -1 3.8 μl of TEOS was added to 800 μl of reconstitution buffer containing liposomes and proteoliposomes. Experiments were performed at 1 h intervals on an SFM2000 (BioLogic Science Instruments) with each rapid mix requiring 80 μL of sample and 80 μL of hyperosmolar buffer. Scattering was monitored at a fixed angle of 90° and data were collected at a wavelength of 438 nm. To obtain the rate constant of water transport, the collected data were fitted to a biexponential function, which was denoted as the k value.
[0097] Circular dichroism (CD) spectra were obtained on a Chirascan™ circular dichroism spectrometer equipped with a Peltier temperature controller. The lamp, monochromator and sample chamber were purged with N2(g) for 5 min before analysis at flow rates of 1 liter / min, 3 liter / min and 1 liter / min, respectively. Spectra were recorded from 190 nm to 250 nm in a quartz cuvette of 1 mm path length using a 1 nm bandwidth and a 10 second time constant. Data below 200 nm were omitted as buffer absorbance below 198 nm caused a high voltage (HV) exceeding the 700 V threshold. Data presented are the average of three scans recorded at 25°C. Data were subjected to background (pure buffer) subtraction before presentation. 1 mg ml -1 Measurements were performed in reconstitution buffer at the lipid concentration, mass of LPR6. To account for the increase in absorption caused by the formation of the silica shell, CD data were normalized to the shift in the applied HT voltage.
[0098] Derivation of a SANS model for silicified proteoliposomes STEM analysis of silicified proteoliposomes shows a core-shell structure in which the proteoliposomes are covered by a thin silica shell. The geometric model parameters of the bilayer and silica shell used for SANS data analysis are shown in Figure 3A. Each proteoliposome has a radius R core The proteoliposome consists of a spherical structure of aquaporin-containing lipid bilayers that encase a liquid-filled core of t. The protein-containing lipid bilayers that make up the shell of the proteoliposome are radially arranged into three layers based on the composition, with a thickness of t. i The inner hydrophilic lipid head region layer, including the protein, has a thickness of D c of hydrophobic lipid tail layer, and thickness t o The total radius of the proteoliposome is therefore divided into the total radius at the equator R tot is defined by R tot is the core radius R core and the thickness of the three layers of the lipid bilayer, t i , D c and t oThis model is the sum of the thickness t silica The silica layer also includes
[0099] Therefore, the total scattered intensity I(q) can be written as:
number
[0100] The scattering amplitude of each concentric spherical layer can be described as:
number
number
number
number
number
number
number
[0101] To illustrate the method of silica deposition onto proteoliposomes, silica was introduced to indicate the fraction of proteoliposomes covered with a silica shell. The parameter f protein was similarly used to indicate the volume fraction of protein in the sample. Both silica and protein were separated by the inner lipid head layer (f sil,i、 f prot,i ), lipid tail layer (f sil,c、 f prot,c ), and the outer lipid head layer (f sil,o、 f prot,o ) f x,i +f x,c +f x,o =1 where the subscript x represents sil or prot. The number of lipids in each proteoliposome, P, is
number
[0102] The contrast between the different layers is Δp i =p head ·(1-f prot,i f protein -f sil,i f silica -f w,i )+p prot f prot,i f protein +p silica f sil,i f silica +p solvent f w,i -p solvent Δp c =p tail ·(1-f prot,c f protein -f sil,c f silica )+p prot f prot,c f protein +p silica f sil,c f silica -p solvent Δp o =p head ·(1-f prot,o f protein -f sil,o f silica -f w,o )+p prot f prot,o f protein +p silica f sil,o f silica +p solvent f w,o -p solvent Δp silica =p silica ·(1-f w,silica )+p solvent f w,silica -p solvent is defined by In the formula, p head , p tail , p silica and psolvent are the scattering length densities (SLDs) of the lipid head group, lipid tail, silica and bulk solvent, respectively.
[0103] Finally, the dry volume of silica deposited on each liposome / proteoliposome was calculated as
number
[0104] result The structural characteristics of liposomes and proteoliposomes were evaluated using DLS and SANS. The polydispersity index (PDI) determined by DLS was 0.15 for liposomes and 0.27 for proteoliposomes. The vesicle size (approximately 2 × 10 -3 Å -1 The broadness of the SANS peaks corresponding to the vesicles located at 124.8 nm ± 2.9 nm and 132.9 ± 7.0 nm, respectively, also suggested polydispersity in sample size. The liposomes and proteoliposomes had Z-avg diameters of 124.8 nm ± 2.9 nm and 132.9 ± 7.0 nm, respectively. The data were also weighted according to number to compensate for non-proportional light scattering contributions from large vesicles, which were apparently present due to the polydispersity of both samples. The weighted average diameters then amounted to 78.0 nm ± 5.1 nm for liposomes and 66.0 nm ± 3.2 nm for proteoliposomes.
[0105] SANS characterization of the samples prior to addition of the silica precursor was performed with two contrasts that matched the scattering length density (SLD) of DO and silica (CMSiO2). Simultaneous fitting of these contrasts to a custom designed core-multishell model yielded diameters of 45 nm, internal lipid head thickness of 9 Å, and lipid tail layer thickness of 34 Å for both liposomes and proteoliposomes. The thickness of the outer lipid head groups was 10 Å for liposomes and 12 Å for proteoliposomes.
[0106] Using SANS, the silicification method and the evolution of the silica shell were studied to elucidate how liposomes and proteoliposomes are affected in the process. The size and composition of the bilayer compartments and the silica shell were obtained. The SANS profile obtained in the course of silicification of proteoliposomes is shown in Figure 2A. A reasonable fit to the silicification method was achieved by adjusting the five fitting parameters: concentration of species in the neutron beam (conc.), fraction of silica-coated liposomes / proteoliposomes (f silica ), the thickness of the outer lipid head (t o ), the thickness of the silica shell (t silica ), and the water content of the silica shell (f w,silica ) was obtained by changing the dry volume of the silica shell (V silica,dry , derived using Equation 1) along with the initial and final fitted values of the selected parameters are shown in Table 2.
number
[0107] V silica,dry is also shown as a function of time in Figure 3B. The data shown in Figure 3B was fitted to the following Avrami-type growth function [Avrami, J. Chem. Phys. 1940, 8:212-224, and Avram, J. Chem. Phys. 1941, 9(2):177-184]:
number
number
[0108] Time-resolved DLS was utilized to study the aggregation behavior of liposomes and proteoliposomes during the silicification process. The scattered light intensity began to increase in both liposome and proteoliposome samples after about 3 hours of silicification (Figure 11). This increase in scattering is attributed to the aggregation of silicified liposomes and proteoliposomes.
[0109] The functionality of aquaporins during and upon silicification was assessed using time-resolved stopped-flow light scattering. As seen in Table 1, proteoliposomes highly retain their water transport capacity upon silicification, as verified by the small changes in k values. The lipid membrane itself appears to become slightly water permeable. The relatively low R obtained from a 10-h fit 2 The value is due to the lower signal-to-noise ratio of vesicle shrinkage due to the presence of large aggregates. [Table 1]
[0110] The effect of silicification on hAQP4 secondary structure was assessed using CD (Figure 2B). The results show that the predominantly α-helical native secondary structure of the protein was largely preserved upon silicification. [Table 2] [Table 3]
[0111] Upon complete silicification and drying, the silica-coated liposomes and proteoliposomes were studied using TEM. Results collected using TEM (Figure 4A,B) and STEM (Figure 4C,D) further explained the geometric and compositional properties of the silicified samples. STEM characterization indicates that the silicified liposomes and proteoliposomes predominantly adopt a core-shell architecture.
[0112] The silicified proteoliposomes were also subjected to elemental mapping. STEM energy dispersive X-ray spectroscopy (EDX) was used to localize the different elements, as can be seen in Figure 5. A STEM high angle annular dark field (HAADF) micrograph of the same sample area is also inserted. The results suggested that the visualized elements were more abundant along the silicified aquaporin-containing lipid bilayer lining the proteoliposomes.
[0113] Additional elemental mapping was performed using energy-filtered (EF) TEM, which is more sensitive to lighter elements compared to EDX and thus was able to detect both nitrogen and hydrogen in addition to sulfur, silicon, carbon, phosphorus and oxygen (Figure 6).
[0114] SANS data modeling revealed that most of the parameters used to describe the system remained constant during silicification of both liposomes and proteoliposomes. In fact, the same five parameters (t o , f silica ,conc.,t silica , and f w,silica ) was sufficient to accurately describe the changes in both samples. In this model, the concentration (conc.) was used as a floating parameter and directly interconnected with the other parameters. Silica-coated liposomes / proteoliposomes (f silicaThe fraction of SiO2 (SiO2) remained constant at 0 during the first 1 and 3.5 h of silicification of liposomes and proteoliposomes, respectively. This "lag phase" was associated with the hydrolysis of the alkoxide precursor, during which the TEOS ester bond was cleaved to finally form silicic acid and ethanol. At pH 8, the process is expected to proceed slowly, since the hydrolysis reaction is catalyzed by acid and base.
[0115] After hydrolysis of the precursor, f silica increased to 1 during a period of 1.5 and 3 h for liposomes and proteoliposomes, respectively. This indicated that silica deposition occurred within a limited time frame, rather than continuously throughout the duration of silicification. An interesting observation was that the thickness of the silica shell did not increase linearly with time. Instead, a layer of lipid bilayer thickness (approximately 4 nm) composed of silicic acid and buffer was placed on the liposomes and proteoliposomes as soon as deposition began. Liposomes and proteoliposomes (without silica shell) remained unchanged except for the outer lipid head layer, which experienced swelling. The outer leaflet of the lipid bilayer is in direct contact with the deposited silicic acid and is therefore subject to changes in the surrounding environment. According to this model, the outer lipid head layer of the template samples consisted of 82% and 86% buffer for liposomes and proteoliposomes, respectively. Especially considering the high proportion of buffer in the initially deposited silicic acid layer (96% buffer in liposomes and 98% in proteoliposomes by the start of deposition), silicic acid interacted closely with the outer lipid head layer. o The overall thickening of can be attributed to the presence of an interfacial water layer between the lipid bilayer and the silica shell.
[0116] t o Also silica did not show a stable increase or decrease throughout the method for either sample, with slight deviations interrupting the overall pattern. Therefore, by employing Eq. 1, t o and t silica the remaining geometric parameters and f w,silicaThe growth kinetics of the silica shell was studied by coupling the volume of the buffer-free silica shell, V, as a function of time. silica,dry is shown in Figure 3B. The evolution of the silica shell volume over time follows a sigmoidal pattern, which was fitted to an Avrami-type growth function (Eq. 2), originally derived for phase transformation processes, particularly crystallization. Different lengths of lag phases resulted in different Avrami parameters β for the silicification of liposomes and proteoliposomes. Thus, a comparison of reaction rates k was not straightforward. Therefore, the half-life of silicification (t 1 / 2 ) was calculated (Equation 3). As shown in Table 3, the silicification of proteoliposomes was significantly higher than that of liposomes (t 1 / 2 This means that the silicification of the liposomes reached half of the plateau volume in slightly less time than the silicification of the proteoliposomes. 1 / 2Since is a composite measure of the onset of the lag phase and exponential phase, another technique was also utilized for comparison. Both shell growth processes were plotted from the onset of exponential growth, excluding the hydrolysis phase of the initial precursor. The growth phases were remarkably similar. It was therefore concluded that the difference in silicification of liposomes and proteoliposomes occurred during the first part of the method, i.e., precursor hydrolysis. Since the only difference between the samples was protein, the presence of protein changed the mechanism of formation of the silica shell. There are two main protein properties that can affect silica shell formation: electrostatic repulsion and steric hindrance. POPC lipids are zwitterionic and therefore neutral at pH 8. On the other hand, hAQP4 has a slightly negative net charge due to its isoelectric point of 7.6. When TEOS is hydrolyzed to silicic acid, a small portion of the silicic acid becomes ionized and therefore negatively charged. Thus, the slightly negative net charge of proteins introduces electrostatic repulsion that may prevent some of the silicic acid from accessing the lipid bilayer head groups. However, this is not very likely to be the only explanation, especially since the silica shell interacts with the lipid heads via hydrogen bonding to the negatively charged phosphatidyl moieties, not the positively charged choline moieties. Therefore, steric hindrance, possibly in combination with electrostatic repulsion, is presented as a more likely option. The C-terminal domain of hAQP4 reaches into the bulk, which may cause the proteoliposomes not to come into direct contact. This also seemed to be true for the silicified proteoliposomes, which did not aggregate to the same extent as the silicified liposomes. Steric hindrance may be the reason for the long lag period of silicification of the proteoliposomes, in terms of the low accessibility of silicic acid to the lipids.
[0117] A similarity between the silicification of liposomes and proteoliposomes was the thickness of the silica shell, which amounted to about 4 nm using these formation conditions. Interestingly, smaller silica particles were present in the silicified and dried samples, which was clearly seen in the TEM (Figure 4B). This indicated that more material was available than was consumed in forming the silica shell. For both samples, the majority of the silica formation seemed to have occurred in the bilayer (Figure 4). It was also interesting to study the arrangement of other elements upon silicification to get an indication as to how the original proteoliposome composition had changed. STEM-EDX showed that the detected elements were most abundant along the silica backing of the proteoliposomes, indicating that the aquaporin-containing lipid bilayer was intact. As the mapping was performed in transmission mode, the maps show a 2D projection of the 3D sample, and therefore elements were detected in other parts of the silicified proteoliposomes as well, albeit at lower concentrations. Complementary elemental mapping was performed using EFTEM, which is more sensitive to lighter elements. Thus, in addition to the elements detected by EDX, nitrogen and hydrogen, which are common components of biological materials, could also be detected. EFTEM elemental mapping confirmed the indications provided when using EDX, with elements associated with aquaporin-containing lipid bilayers being enriched in the silicified regions lining the proteoliposomes.
[0118] CD studies revealed that the protein remained intact throughout the silicification method (Figure 2B). Changes in the helicity of the protein structure are typically assessed by changes to the absorption band at 222 nm, which corresponds to the n → π* transition in the peptide bond. Judging from the CD data, the absorption at 222 nm was almost identical, which means that the transmembrane portion of hAPQ4 was intact. Thus, the hydrophobic tail region of the lipid bilayer remained the same, and as a result, the protein secondary structure was preserved. The reason for the small change in amplitude at 209 nm could be small modifications to the disordered parts of the protein, which would be plausible since some of those parts are exposed to silica.
[0119] This example disclosed a method to stabilize hAQP4-containing proteoliposomes by coating them with a thin silica shell. Importantly, the native conformation of the protein was maintained upon silicification.
[0120] The above embodiments should be understood as some illustrative examples of the present invention. Those skilled in the art will understand that various modifications, combinations and changes can be made to the embodiments without departing from the scope of the present invention. In particular, different part solutions in different embodiments can be combined in other configurations, if technically possible.
Claims
1. A polymeric membrane structure (2) comprising a membrane (3) containing an integral membrane protein (1) that allows water to pass through, said membrane (3) having a first surface coated with a silica layer (4).
2. 2. The polymeric membrane structure according to claim 1, wherein the membrane (3) is a bilayer membrane (3) comprising amphiphilic molecules.
3. The membrane (3) is a lipid bilayer membrane (3), and the amphipathic lipid of the lipid bilayer (3) is preferably phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol, cardiolipin, cholesterol, sphingomyelin, asolectin, diphytanoylphosphatidylcholine (DPhPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-dihexanoyl-sn- Glycero-3-phosphoethanolamine (DHPE), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), dimyristoyl phosphatidylserine (DMPS), dimyristoyl phosphatidylglycerol, dilauroyl phosphatidylcholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG), 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (14:0 lysoPC such as 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 lysoPC), 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (16:0 lysoPE) or 1-oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (18:1 lyso-PE such as 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dierucoyl-sn-glycero-3-phosphate (DEPA), 1,2-erucoyl-sn-glycero-3-phosphocholine (DEPC), 1,2-dierucoyl-sn-alicero-3-phosphoethanolamine (DEPE), 1,2-linoleoyl-sn-glycero-3-phosphocholine (DLOPC), 1,2-dilauroyl-sn-glycero-3-phosphate (DLPA), 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE), 1,2-dilauroyl-sn-glycero-3-phosphoserine (DLPS), 1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA), 1,2-Dimyristoyl-sn-glycero-3-phosphoserine (DMPS), 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), 1,2-oleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS), 1,2-dipalmitoyl-sn-glycero-3-phospho 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPA), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 1,2-dipalmitoyl-sn-glycero-3-phosphoserine (DPPS), 1,2-distearoyl-sn-glycero-3-phosphate (DSPA), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-diostearoyl-sn-glycero-3-phosphoethanolamine (DSPE), 1-myristoyl 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (MSPC), 1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine (PMPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (PSPC) ), 1-stearoyl-2-myristoyl-sn-glycero-3-phosphocholine (SMPC), 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine (SPPC), lipids from cell membranes, lipids from cell organelles, cross-linkable lipids, and mixtures thereof, preferably POPC.
4. 3. The polymeric membrane structure of claim 2, wherein the amphiphilic molecules are selected from amphiphilic AB, ABA and ABC copolymers and mixtures thereof, such as poly(methyloxazoline)-poly(dimethylsiloxane)-poly(methyloxazoline) (PMOXA-PDMS-PMOXA), poly(2-ethyl-2-oxazoline)-b-poly(dimethylsiloxane)-b-poly(2-ethyl-2-oxazoline) (PEtOz-PDMS-PEtOz) and mixtures thereof.
5. The polymer membrane structure according to any one of claims 1 to 4, wherein the membrane (3) is a proteoliposome or a proteopolymersome, and the outer surface of the proteoliposome or the proteopolymersome is covered with the silica layer (4).
6. The integral membrane protein (1) that allows water to pass through is an aquaporin, preferably hAQP0, hAQP1, hAQP2, hAQP3, hAQP4, hAQP5, hAQP6, hAQP7, hAQP8, hAQP9, hAQP10, hAQP11, hAQP12, preferably hAQP0, hAQP1, hAQP2, hAQP4, hAQP5, hAQP6, or hAQP8, more preferably hAQP11. The polymer membrane structure according to any one of claims 1 to 5, wherein the polymer membrane structure is selected from the group consisting of human aquaporins (hAQP) such as APQ4; bovine aquaporins such as bAQP1; fish aquaporins such as cpAQP1aa; yeast aquaporins such as Aqy1; plant aquaporins such as SoPIP2;1, AtTIP2;1 or AtPIP2;4; bacterial aquaporins such as AqpZ; and mixtures thereof.
7. The polymer membrane structure according to any of the preceding claims, wherein said silica layer (4) has an average thickness selected in the range of 0.1 nm to 1000 nm, preferably 1 nm to 100 nm, more preferably 1 nm to 10 nm.
8. The polymer membrane structure according to any one of claims 1 to 7, wherein the water-permeable integral membrane protein (1) is capable of passing water through the membrane (3) in the presence of the silica layer (4).
9. The polymeric membrane structure according to any of claims 1 to 8, wherein said silica layer (4) is a functionalized silica layer (4), preferably comprising a silane such as fluoroalkylsilane (FAS), an alkoxysilane such as hexamethyldisilazane (HMDZ), or a combination thereof.
10. A filtration device (5), A porous support (6) comprising a plurality of pores (7); The polymer membrane structure (2) according to any one of claims 1 to 9. A filtration device (5).
11. 11. The filtration device according to claim 10, wherein the polymer membrane structure (2) is provided on the surface of the porous support (6) and / or within the pores (7) of the porous support (6).
12. 12. The filtering device according to claim 10 or 11, wherein the porous support (6) is made of a material selected from the group consisting of polymers such as polysulfone, polyethersulfone, polyphenylsulfone, polyetherethersulfone, polyetherketone, polyetheretherketone, polyphenylene ether, polydiphenylphenylene ether, cellulose, polyvinylene cellulose acetate, cellulose diacetate, cellulose triacetate, cellulose nitrate, polyphenylene sulfide, nitrocellulose, acetylated methylcellulose, polyacrylonitrile, polyvinyl alcohol, polycarbonate, organosiloxane carbonate, polyester carbonate, organopolysiloxane, polyethylene oxide, polyamide, polyimide, polyamideimide, polybenzimidazole, polyolefin, polyacrylonitrile, nylon and mixtures thereof; metals such as aluminum, titanium, zirconium, iron or oxides thereof, or oxides of said metals; silicon dioxide; glass fibers; and mixtures thereof.
13. The filtration device (5) comprises a polymer membrane structure (2) according to claim 9, and the functional groups of the functionalized silica layer (4) link the polymeric membrane structure (2) to the porous support (6); The filtration device according to any one of claims 10 to 12.
14. A method for preparing a water filtrate, comprising filtering an aqueous solution through a polymeric membrane structure (2) according to any one of claims 1 to 9 or a filtration device (5) according to any one of claims 10 to 13 to obtain the water filtrate.
15. A method for concentrating a compound dissolved or dispersed in an aqueous solution, comprising filtering the aqueous solution with a polymeric membrane structure (2) according to any one of claims 1 to 9 or a filtering device (5) according to any one of claims 10 to 13 to obtain a water filtrate free of the compound and a retentate containing the compound in a higher concentration than the aqueous solution.
16. A method for preparing a polymeric membrane structure (2), comprising contacting a membrane (3) containing a water-permeable integral membrane protein (1) with a silica precursor to form a silica layer (4) coated on a first surface of the membrane (3).
17. A method for preparing a filtration device (5), comprising the steps of: depositing a membrane (3) containing a water-permeable integral membrane protein (1) on and / or within a porous support (6); contacting said membrane (3) containing a water-permeable integral membrane protein (1) deposited on and / or within said porous support (6) with a silica precursor to form a silica layer (5) coated on a first surface of said membrane (3); A method comprising:
18. The silica precursor may be selected from the group consisting of silicon alkoxides such as tetramethylorthosilicate (TMOS), tetraethylorthosilicate (TEOS), tetrapropylorthosilicate, tetrabutylorthosilicate, methyltriethoxysiloxane (MTES), dimethyldiethoxysiloxane (DMDES), tetrakis(glycerol)orthosilicate (TGS) and tetrakis-(2-hydroxyethyl)-orthosilicate (THEOS); allyltrimethoxysilane, (3-aminopropyl)triethoxysilane, butyltrichlorosilane, chloropentamethyldisilane, 1,2-dichlorotetramethyldisilane, diethoxydiphenylsilane, [3-(diethylamino)propyl]trimethoxysilane, dimethoxydimethylsilane, dimethoxy(methyl)octylsilane, (3-glycidyloxypropyl)trimethoxysilane, hexamethyldisilane, isobutyl(trimethoxysilane), butyltrichlorosilane, chloropentamethyldisilane, 1,2-dichlorotetramethyldisilane, diethoxydiphenylsilane, [3-(diethylamino)propyl]trimethoxysilane, dimethoxydimethylsilane, dimethoxy(methyl)octylsilane, (3-glycidyloxypropyl)trimethoxysilane, hexamethyldisilane, isobutyl(trimethoxysilane), 18. The method according to claim 16 or 17, wherein the silane is selected from the group consisting of silane, methyltrichlorosilane, pentamethyldisilane, n-propyltriethoxysilane, tetraethylsilane, 1,1,2,2-tetramethyldisilane, tetramethylsilane, triethoxymethylsilane, triethoxyoctylsilane, trimethoxyphenylsilane, triethoxyphenylsilane, triethoxyvinylsilane, trimethoxymethylsilane, γ-aminopropyltriethoxysilane, silanes such as silicon tetrachloride (tetrachlorosilane), silicon tetrabromide (tetrabromidosilane) or γ-aminopropylsilanetriol (APSTOL); silicates such as sodium silicate; silanols such as tris(tert-pentoxy)silanol or tris(tert-butoxy)silanol; silazanes, N-sec-butyl(trimethylsilyl)amine, and combinations thereof, preferably TEOS.
